Ingo Schmidt‐Wolf
Impact in
- Oncology top 0.5%
- Pancreatic and Hepatic Oncology Research
- Neutropenia and Cancer Infections
- Family Practice top 2%
Papers in
- Oncology 29
- Cancer Treatment and Pharmacology 6
- Hematology 19
- Multiple Myeloma Research and Treatments 15
- Co-authors
- Axel Glasmacher (13 shared papers)Harald Schmalenberg (1 shared paper)Bernd Doerken (1 shared paper)Hanno Riess (1 shared paper)Helmut Oettle (1 shared paper)Jan M. Langrehr (1 shared paper)L. Roll (1 shared paper)Marco Niedergethmann (1 shared paper)
- Journals
- Blood (10 papers)International Journal of Molecular Sciences (4 papers)Journal of Clinical Oncology (3 papers)Anticancer Research (2 papers)Hematological Oncology (2 papers)
- Partner nations
- GermanyUnited StatesChina
In The Last Decade
Ingo Schmidt‐Wolf
70 papers receiving 3.7k citations
Ingo Schmidt‐Wolf's Hit Papers
Peers
Comparison fields: 5 of 103
- Oncology 2.4k
- Family Practice 62
- Hematology 359
- Cancer Research 374
- Immunology 461
Countries citing papers authored by Ingo Schmidt‐Wolf
This map shows the geographic impact of Ingo Schmidt‐Wolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingo Schmidt‐Wolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingo Schmidt‐Wolf more than expected).
Fields of papers citing papers by Ingo Schmidt‐Wolf
This network shows the impact of papers produced by Ingo Schmidt‐Wolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingo Schmidt‐Wolf. The network helps show where Ingo Schmidt‐Wolf may publish in the future.
Co-authors
The 25 scholars most cited alongside Ingo Schmidt‐Wolf, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer Hit paper breakdown → | 2007 | 1823 |
| 2 | 2003 | 212 | |
| 3 | 1999 | 188 | |
| 4 | 2006 | 186 | |
| 5 | 2003 | 140 | |
| 6 | 2000 | 123 | |
| 7 | 2004 | 119 | |
| 8 | 2010 | 108 | |
| 9 | 2006 | 81 | |
| 10 | 1999 | 81 | |
| 11 | 2006 | 71 | |
| 12 | 2006 | 63 | |
| 13 | 1998 | 61 | |
| 14 | 2003 | 51 | |
| 15 | 2007 | 43 | |
| 16 | 2013 | 29 | |
| 17 | 2015 | 25 | |
| 18 | 2017 | 23 | |
| 19 | 2003 | 23 | |
| 20 | 2006 | 21 |
About Ingo Schmidt‐Wolf
Ingo Schmidt‐Wolf is a scholar working on Oncology, Hematology, Immunology, Molecular Biology and Epidemiology, having authored 74 papers that have together received 3.8k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (15 papers), Immune Cell Function and Interaction (15 papers), Protein Degradation and Inhibitors (8 papers), Lymphoma Diagnosis and Treatment (8 papers), T-cell and B-cell Immunology (6 papers), Cancer Treatment and Pharmacology (6 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Immunotherapy and Immune Responses (5 papers). The work is most often cited by research in Oncology (2.4k citations), Family Practice (62 citations), Hematology (359 citations), Cancer Research (374 citations) and Immunology (461 citations). Ingo Schmidt‐Wolf has collaborated with scholars based in Germany, United States and China. Frequent co-authors include Axel Glasmacher, Harald Schmalenberg, Bernd Doerken, Hanno Riess, Helmut Oettle, Jan M. Langrehr, L. Roll, Marco Niedergethmann, Wolf O. Bechstein and P. Neuhaus. Their work appears in journals such as Blood, International Journal of Molecular Sciences, Journal of Clinical Oncology, Anticancer Research and Hematological Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.